首页> 外文期刊>American journal of medical genetics, Part A >Analysis of skeletal dysplasias in the Utah population
【24h】

Analysis of skeletal dysplasias in the Utah population

机译:犹他州人群的骨骼发育不良的分析

获取原文
获取原文并翻译 | 示例
           

摘要

The Utah Birth Defect Network (UBDN) collects population-based data for Utah on births from all resident women. The prevalence of skeletal dysplasias and epidemiologic characteristics/outcomes were evaluated. Cases categorized as a skeletal dysplasia from all live births, stillbirths, and pregnancy terminations (TAB) between 1999 and 2008 were reviewed by three clinical geneticists. After case review, 153 were included for analysis (88% live births, 3% stillborn, 9% TAB), and categorized by groupings defined by molecular, biochemical, and/or radiographic criteria as outlined in the 2010 Nosology and Classification of Genetic Skeletal Disorders. The overall prevalence for skeletal dysplasias was 3.0 per 10,000 births, and 20.0 per 10,000 stillbirths. The most common diagnostic groups were osteogenesis imperfecta (OI; n=40; 0.79 per 10,000), thanatophoric dysplasia (n=22; 0.43 per 10,000), achondroplasia (n=18; 0.35 per 10,000), and cleidocranial dysplasia (n=6; 0.12 per 10,000). The most common groups based on the 2010 Nosology and Classification of Genetic Skeletal Disorders were the FGFR3 chondrodysplasia group (n=41; 0.81 per 10,000), the OI/decreased bone density group (n=40; 0.79 per 10,000), and the type 2 collagen group (n=10; 0.2 per 10,000). Median age of postnatal diagnosis was 30 days (range 1-2,162). Of those deceased, 88% were prenatally suspected; of those alive 29% prenatally suspected. Median age of death for live born individuals was 1 day (range 1-1,450 days). Previously reported prevalence rates vary, but our data provide a population-based approach not limited to the perinataleonatal period. Understanding the range for survival within each group/diagnosis is beneficial for health care providers when counseling families.
机译:犹他州出生缺陷网络(UBDN)收集了来自犹他州的所有常住妇女出生的人口数据。评估骨骼发育不良的发生率和流行病学特征/结果。由三位临床遗传学家对1999年至2008年之间所有活产,死产和终止妊娠(TAB)归类为骨骼发育不良的病例进行了审查。病例审查后,纳入153份进行分析(88%活产,3%死产,9%TAB),并按分子,生化和/或放射学标准定义的分组进行分类,如《 2010年分子遗传学和遗传骨架分类》中概述的那样疾病骨骼发育不良的总体患病率为每10,000例婴儿3.0例,每10,000例死产20.0例。最常见的诊断组是成骨不全症(OI; n = 40;每10,000例0.79),痛觉不典型增生(n = 22;每10,000例0.43),软骨发育不全(n = 18;每10,000例0.35)和颅骨发育不良(n = 6 ; 0.12 / 10,000)。根据2010年《疾病分类和遗传性骨骼疾病分类》,最常见的组是FGFR3软骨发育不良组(n = 41; 0.8 / 10,000),OI /骨密度降低组(n = 40; 0.79 / 10,000)和类型2组胶原蛋白(n = 10;每10,000个中有0.2个)。产后诊断的中位年龄为30天(范围为1-2162)。在死者中,有88%被怀疑是产前检查。尚有29%的产前怀疑者中。活产婴儿的平均死亡年龄为1天(范围为1-1450天)。先前报道的患病率各不相同,但我们的数据提供了一种基于人群的方法,不仅限于围产期/新生儿期。在为家庭提供咨询时,了解每个组/诊断中的生存范围对医疗保健提供者是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号